Chylous ascites is the accumulation of chyle (lymphatic fluid) in the peritoneal cavity. It can be the result of congenital defects of the lymphatic system, inflammatory processes, malignancy ...

Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...

New Jersey, USA-based Imunon announced new translational data from the Phase II OVATION 2 Study of IMNN-001, an ...

Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas® ...

The SUNCHIP system, which helps to regulate the temperature and flow of chemotherapy liquid in the peritoneal cavity, was developed to combine performance, simplicity, safety and economy.

Imunon (IMNN) announced new translational data from ongoing analyses of results from the Company’s Phase 2 OVATION 2 Study of IMNN-001, its ...

This valuable work presents how PRDM16 plays a critical role during colloid plexus development, through regulating BMP signaling. Solid evidence supports the context-dependent gene regulatory ...

IMUNON announced that its new DNA-based immunotherapy for advanced ovarian cancer has shown encouraging results in the ...

Stage 3 ovarian cancer has spread outside the pelvis into the abdominal cavity or to lymph nodes. Treatment includes surgery and chemotherapy. Stage 3A1 means the cancer has spread to the lymph nodes ...